Skip to content

Health— page 28

health

Novonesis expects results from weight-loss drug supplement study in 2027

By Vera Dvorakova and Jesus Calero Aug 20 (Reuters) – Danish biosolutions maker Novonesis expects results in the second half of 2027 from research with Novo Nordisk into whether microbiome supplements could provide additional benefits alongside GLP-1 weight-loss drugs, its chief executive told Reute

· SRN Health
health

Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, WHO says

Aug 20 (Reuters) – The Democratic Republic of Congo has been allocated 70,000 doses of Merck’s Ervebo vaccine for Ebola, the World Health Organization said on Thursday, as the country attempts to contain its biggest-ever outbreak of the deadly disease. Here are some details: • Last week Congo had re

· SRN Health
Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, WHO says
health

Congo’s M23 rebels introduce new movement restrictions over Ebola concerns

Aug 20 (Reuters) – The AFC/M23 rebel alliance in Democratic Republic of Congo, which has highlighted its ability to tackle the spread of Ebola in territory it controls, has said it will impose new restrictions on people’s movements to and from Ebola-affected government-held zones. • Shared taxis on

· SRN Health
Congo’s M23 rebels introduce new movement restrictions over Ebola concerns
health

New CDC director acknowledges agency problems in first large staff meeting

NEW YORK (AP) — In her first large staff meeting, the new director of the Centers for Disease Control and Prevention promised Wednesday to advocate for the agency while acknowledging that congressionally funded programs lacked staff and employees were feeling burned out. Dr. Erica Schwartz also said

· SRN Health
New CDC director acknowledges agency problems in first large staff meeting
health

Ultragenyx’s gene therapy wins first FDA approval for rare metabolic disorder

By Sneha S K and Padmanabhan Ananthan Aug 19 (Reuters) – Ultragenyx Pharmaceutical said on Wednesday that its gene therapy became the first to receive the U.S. Food and Drug Administration’s approval to treat a rare metabolic disorder, sending its shares up 7.5% in after-hours trading. The drug, bra

· SRN Health
Ultragenyx’s gene therapy wins first FDA approval for rare metabolic disorder
health

Analysis-Moderna, Merck breakthrough could usher in wave of cancer vaccines

CHICAGO, Aug 19 (Reuters) – Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many types of tumors. Unlike chemotherapy, which kills both healthy and cancerous cells, or immunotherapy, w

· SRN Health
Analysis-Moderna, Merck breakthrough could usher in wave of cancer vaccines
health

US FDA approves Regeneron’s rare bone disorder drug

By Bageshri Banerjee and Christy Santhosh Aug 19 – The U.S. FDA on Wednesday approved Regeneron’s drug for a rare genetic disorder after it significantly reduced abnormal bone formation in certain soft tissues. New York-based Regeneron’s shares rose 4%. The drug, garetosmab, branded as Pasatru, was

· SRN Health
US FDA approves Regeneron’s rare bone disorder drug
health

West Nile virus outbreak kills four in North Macedonia

Aug 19 (Reuters) – Four people have died from West Nile fever out of 38 testing positive for the disease so far this year in North Macedonia, with three of them dying in the past week, the health ministry said on Wednesday. The virus, which mostly spreads to people through mosquito bites, can cause

· SRN Health
health

China’s top drugmaker Hengrui sees profit growth squeezed by bulk-buying programs

BEIJING, Aug 19 (Reuters) – Jiangsu Hengrui Pharmaceuticals, China’s biggest drugmaker by market value, reported a 0.34% rise in first-half ​net profit on Wednesday, as its generics business remained under pressure from bulk-procurement programs designed to lower healthcare costs. Hengrui said reven

· SRN Health
China’s top drugmaker Hengrui sees profit growth squeezed by bulk-buying programs
health

Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results

Aug 19 (Reuters) – Moderna’s personalized mRNA cancer therapy, developed with Merck, reduced the risk of melanoma recurrence and spread when used in combination with the U.S. drugmaker’s blockbuster treatment Keytruda in a late-stage trial. The interim results showed statistically significant improv

· SRN Health
Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results
health

France recorded 1,243 excess deaths during July heatwaves

PARIS, Aug 19 (Reuters) – France recorded 1,243 excess deaths between July 3 and July 22 when the country was hit by exceptionally high temperatures, the country’s health ministry said on Wednesday. • The count includes all deaths regardless of their cause and is an estimate based on death certifica

· SRN Health
France recorded 1,243 excess deaths during July heatwaves
health

Health Round: Platelets can be chilled and stored for weeks, not days, study shows

By Nancy Lapid Aug 19 (Reuters) – We also share data confirming that U.S. airline flight crews are at high risk of cancer from cosmic radiation. CHILLING PLATELETS CAN SAFELY EXPAND THEIR AVAILABILITY Researchers who tested the use of refrigerated platelets say their results could more than triple t

· SRN Health
Health Round: Platelets can be chilled and stored for weeks, not days, study shows
health

Lundbeck sees no slowdown in key drugs despite cautious 2026 outlook, CEO says

By Jesus Calero and Vera Dvorakova Aug 19 (Reuters) – H. Lundbeck sees no slowdown in demand for its two main growth drugs, its chief executive said on Wednesday, after the Danish drugmaker reiterated its full-year outlook despite stronger-than-expected second-quarter sales. “There is no concern aro

· SRN Health
health

Novo begins study to find lowest effective dose for Wegovy pill

LONDON, Aug 19 (Reuters) – Danish drugmaker Novo Nordisk is testing lower doses of its Wegovy pill in a new late-stage study to find the lowest dose that still helps patients lose weight, according to a U.S. clinical trials database. Novo is under pressure after losing ground to U.S. rival Eli Lilly

· SRN Health
Novo begins study to find lowest effective dose for Wegovy pill
health

UK’s Smith+Nephew CFO John Rogers to step down for external role

Aug 19 (Reuters) – Smith+Nephew said on Wednesday its finance chief John Rogers would step down at the end of September to take up an external position in the United States, ending his roughly two-and-a-half-year tenure with the medical products company. Here are some more details: • The departure f

· SRN Health
health

Ebola cases in Congo exceed 5,000, government data shows

NAIROBI, Aug 19 (Reuters) – The number of confirmed Ebola cases in the Democratic Republic of Congo now exceeds 5,000, government data showed late on Tuesday, as health officials warn that response efforts are failing to contain the deadly disease. Congo’s 17th Ebola epidemic turned into the biggest

· SRN Health
Ebola cases in Congo exceed 5,000, government data shows
health

KKR leads bidding race for minority stake in Malaysia’s Avisena, sources say

By Yantoultra Ngui SINGAPORE, Aug 19 (Reuters) – KKR & Co has emerged as the preferred bidder to buy a minority stake in Avisena Healthcare in a deal that could value the Malaysian healthcare firm at about 1.5 billion ringgit ($370 million), two people with direct knowledge of the matter said. • The

· SRN Health
KKR leads bidding race for minority stake in Malaysia’s Avisena, sources say
health

Cyclosporiasis cases in US climb to 15,716, CDC says

Aug 18 (Reuters) – The Centers for Disease Control and Prevention on Tuesday reported 15,716 confirmed cases of cyclosporiasis in the United States, an increase of 1,821 cases from a week ago. Here are more details: • The CDC said it has received reports of 15,716 confirmed cases of cyclosporiasis a

· SRN Health
Cyclosporiasis cases in US climb to 15,716, CDC says
health

The Media Line: Can Syria Do Without Russian Wheat?

Can Syria Do Without Russian Wheat? Economist Yafa Nawaf told TML that sustainably eliminating the need for wheat imports depends on continued support for producers, access to fertilizer, seed, affordable fuel, investment in irrigation networks, dams, and storage capacity By Rizik Alabi / The Media

· SRN Health
The Media Line: Can Syria Do Without Russian Wheat?
health

The best fabric for extreme heat? It’s more complicated than you think

When it’s really hot out, getting dressed seems pretty simple: Wear something light, loose and made for summer. But textile researchers say it’s actually a little more complicated than that. The fabric matters. But so does how heavy it is, how the clothing is made, how it fits and even what color it

· SRN Health
The best fabric for extreme heat? It’s more complicated than you think